A carregar...
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
The U.S. Food and Drug Administration recently marked 10 years since first updating the labeling for warfarin (often referred to as the “poster child” of pharmacogenomics) to include information regarding the potential impact of CYP2C9 and VKORC1 genetic variation on warfarin dosing requirements and...
Na minha lista:
| Publicado no: | JACC Basic Transl Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6115648/ https://ncbi.nlm.nih.gov/pubmed/30175278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2018.06.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|